v3.26.1
Note 13 - Noncontrolling Interest - Schedule of Noncontrolling Interest (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
NCI – equity - December 31, 2025 $ 24,988 $ 38,932 $ 22,300 $ (7,033)
Net loss attributable to NCI (6,598) (12,324) (7,662) 6,300
Impact of subsidiary equity transactions   0 0 0
Stock-based compensation expense 8 7 16 300
NCI – equity – June 30, 2026 19,307 28,159 19,307 28,159
Noncontrolling Interest [Member]        
NCI – equity - December 31, 2025 (14,535) (6,062) (11,667) (4,538)
Net loss attributable to NCI     (2,218)  
Impact of subsidiary equity transactions   (5,507) (1,872) (7,928)
Stock-based compensation expense 8 7 16 300
NCI – equity – June 30, 2026 $ (15,741) $ (9,371) (15,741) $ (9,371)
Noncontrolling Interest [Member] | Veris Health [Member]        
Stock-based compensation expense     $ 16